Taylor-Robinson D, Furr PM, Hanna NF. Microbiological and serological study of non-gonococcal urethritis with special reference to Mycoplasma genitalium. Genitourin Med. 1985;61(5):319–24.
PubMed PubMed Central CAS Google Scholar
Huaman JL, Bradshaw CS, Chua TP, Plummer EL, Danielewski JA, Vodstrcil LA, Jensen JS, Garland SM, Wild N, Murray GL. Factors that contribute to the success of primary isolation of Mycoplasma genitalium from clinical samples. J Med Microbiol. 2025;74(7):002040.
Article PubMed PubMed Central CAS Google Scholar
Jensen JS, Borre MB, Dohn B. Detection of Mycoplasma genitalium by PCR amplification of the 16S rRNA gene. J Clin Microbiol. 2003;41(1):261–6.
Article PubMed PubMed Central CAS Google Scholar
Sonnenberg P, Ison CA, Clifton S, Field N, Tanton C, Soldan K, Beddows S, Alexander S, Khanom R, Saunders P, et al. Epidemiology of Mycoplasma genitalium in British men and women aged 16–44 years: evidence from the third National survey of sexual attitudes and lifestyles (Natsal-3). Int J Epidemiol. 2015;44(6):1982–94.
Article PubMed PubMed Central Google Scholar
Torrone EA, Kruszon-Moran D, Philips C, Morris MR, Bowden KE, Papp J, et al. Prevalence of urogenital Mycoplasma genitalium infection, united States, 2017 to 2018. Sex Transm Dis. 2021;48(11):e160-2.
Article PubMed PubMed Central Google Scholar
Salado-Rasmussen K, Jensen JS. Mycoplasma genitalium testing pattern and macrolide resistance: a Danish nationwide retrospective survey. Clin Infect Dis. 2014;59(1):24–30.
Article PubMed PubMed Central Google Scholar
Andersen B, Sokolowski I, Ostergaard L, Kjolseth Moller J, Olesen F, Jensen JS. Mycoplasma genitalium: prevalence and behavioural risk factors in the general population. Sex Transm Infect. 2007;83(3):237–41.
Read TRH, Murray GL, Danielewski JA, Fairley CK, Doyle M, Worthington K, Su J, Mokany E, Tan LT, Lee D, et al. Symptoms, Sites, and significance of Mycoplasma genitalium in men who have sex with men. Emerg Infect Dis. 2019;25(4):719–27.
Article PubMed PubMed Central CAS Google Scholar
Jensen JS. Mycoplasma genitalium: the aetiological agent of urethritis and other sexually transmitted diseases. J Eur Acad Dermatol Venereol. 2004;18(1):1–11.
Htaik K, Vodstrcil LA, Plummer EL, Sfameni AM, Machalek DA, Manhart LE, Bradshaw CS. Systematic review and meta-analysis of the association between Mycoplasma genitalium and pelvic inflammatory disease (PID). Clin Infect Dis. 2024;Online ahead of print:ciae295.
Lis R, Rowhani-Rahbar A, Manhart LE. Mycoplasma genitalium infection and female reproductive tract disease: a meta-analysis. Clin Infect Dis. 2015;61(3):418–26.
Manhart LE, Geisler WM, Bradshaw CS, Jensen JS, Martin DH. Weighing potential benefits and harms of Mycoplasma genitalium testing and treatment approaches. Emerg Infect Dis. 2022;28(8):e220094.
Article PubMed PubMed Central Google Scholar
Jensen JS, Unemo M. Antimicrobial treatment and resistance in sexually transmitted bacterial infections. Nat Rev Microbiol. 2024;22(7):435–50.
Article PubMed CAS Google Scholar
Rudman T, Rowlands RS, Jensen JS, Beeton ML, On Behalf Of The Escmid Study Group, For M, Chlamydia Infections E. JMM profile: Mycoplasma genitalium: a small, yet significant pathogen. J Med Microbiol. 2025;74(4):001984.
Article PubMed PubMed Central CAS Google Scholar
Jensen JS, Bradshaw C. Management of Mycoplasma genitalium infections - can we hit a moving target? BMC Infect Dis. 2015;15:343.
Article PubMed PubMed Central Google Scholar
Lau A, Bradshaw CS, Lewis D, Fairley CK, Chen MY, Kong FY, et al. The efficacy of azithromycin for the treatment of genital Mycoplasma genitalium: a systematic review and meta-analysis. Clin Infect Dis. 2015;61(9):1389–99.
Bradshaw CS, Jensen JS, Tabrizi SN, Read TR, Garland SM, Hopkins CA, et al. Azithromycin failure in Mycoplasma genitalium urethritis. Emerg Infect Dis. 2006;12(7):1149–52.
Article PubMed PubMed Central CAS Google Scholar
Jensen JS, Bradshaw CS, Tabrizi SN, Fairley CK, Hamasuna R. Azithromycin treatment failure in Mycoplasma genitalium-positive patients with nongonococcal urethritis is associated with induced macrolide resistance. Clin Infect Dis. 2008;47(12):1546–53.
Article PubMed CAS Google Scholar
Bradshaw CS, Chen MY, Fairley CK. Persistence of Mycoplasma genitalium following azithromycin therapy. PLoS One. 2008;3(11):e3618.
Article PubMed PubMed Central Google Scholar
Chua TP, Vodstrcil LA, Murray GL, Plummer EL, Jensen JS, Unemo M, Chow EPF, Low N, Whiley DM, Sweeney EL, et al. Evolving patterns of macrolide and fluoroquinolone resistance in Mycoplasma genitalium: an updated systematic review and meta-analysis. Lancet Microbe. 2025;6(7):101047.
Mitja O, Suner C, Giacani L, Vall-Mayans M, Tiplica GS, Ross JDC, Bradshaw CS. Treatment of bacterial sexually transmitted infections in europe: gonorrhoea, Mycoplasma genitalium, and syphilis. Lancet Reg Health Eur. 2023;34:100737.
Article PubMed PubMed Central Google Scholar
World Health Organisation guidelines for the management of symptomatic sexually transmitted infections. 2021 https://www.ncbi.nlm.nih.gov/pubmed/34370424
Wada K, Hamasuna R, Sadahira T, Araki M, Yamamoto S. UAA-AAUS guideline for M. genitalium and non-chlamydial non-gonococcal urethritis. J Infect Chemother. 2021;27(10):1384–8.
Article PubMed CAS Google Scholar
Lee SJ, Choi JB, Bae S, Na SW, Jung HD, Jung HJ, et al. 2023 Korean sexually transmitted infections treatment guidelines for Mycoplasma genitalium by KAUTII. Investig Clin Urol. 2024;65(1):16–22.
Jensen JS, Cusini M, Gomberg M, Moi H, Wilson J, Unemo M. 2021 European guideline on the management of Mycoplasma genitalium infections. J Eur Acad Dermatol Venereol. 2022;36(5):641–50.
Article PubMed CAS Google Scholar
Ong JJ, Bourne C, Dean JA, Ryder N, Cornelisse VJ, Murray S, Kenchington P, Moten A, Gibbs C, Maunsell S, et al. Australian sexually transmitted infection (STI) management guidelines for use in primary care 2022 update. Sex Health. 2023;20(1):1–8.
Workowski KA, Bachmann LH, Chan PA, Johnston CM, Muzny CA, Park I, et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep. 2021;70(4):1–187.
Article PubMed PubMed Central Google Scholar
Soni S, Fifer H, Al-Shakarchi Y, Bassett J, Mbaulu J, Pinto-Sander N, Strodtbeck S, Rayment M. British Association of Sexual Health and HIV National guideline for the management of infection with Mycoplasma genitalium, 2025. Int J STD AIDS 2025: on line ahead of print.
Bissessor M, Tabrizi SN, Twin J, Abdo H, Fairley CK, Chen MY, Vodstrcil LA, Jensen JS, Hocking JS, Garland SM, et al. Macrolide resistance and Azithromycin failure in a Mycoplasma genitalium-infected cohort and response of Azithromycin failures to alternative antibiotic regimens. Clin Infect Dis. 2015;60(8):1228–36.
Article PubMed CAS Google Scholar
Murray GL, Bradshaw CS, Bissessor M, Danielewski J, Garland SM, Jensen JS, et al. Increasing macrolide and fluoroquinolone resistance in Mycoplasma genitalium. Emerg Infect Dis. 2017;23(5):809–12.
Article PubMed PubMed Central Google Scholar
Deguchi T, Ito S, Yasuda M, Kondo H, Yamada Y, Nakane K, et al. Emergence of Mycoplasma genitalium with clinically significant fluoroquinolone resistance conferred by amino acid changes both in GyrA and parC in Japan. J Infect Chemother. 2017;23(9):648–50.
Hamasuna R, Le PT, Kutsuna S, Furubayashi K, Matsumoto M, Ohmagari N, et al. Mutations in parC and GyrA of moxifloxacin-resistant and susceptible Mycoplasma genitalium strains. PLoS One. 2018;13(6):e0198355.
Comments (0)